FundedIQ
Biotechnology

iProov: Funding, Investors & Team (Sep 2026)

iProov is a cyber-security business based in London, providing strong biometric identity authentication of online users. It focuses on enabling users to log into online services simply, yet, securely. iProov specializes in facial recognition software. iProov is led by a team combining senior experience in growing global, high performance mobile and cloud services, with world class academic research expertise. The business has won many innovation grants from InnovateUK and the UK Government's innovation agency. iProov was established in 2011.

www.iproov.com LinkedIn London, United Kingdom 101-250 employees
Total raised
$70.0M
Rounds
1
Latest
Private Equity
Jan 2022

iProov has raised $70.0M across 1 funding round on record, the most recent a Private Equity of $70.0M announced in Jan 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

iProov Company Profile and Key Stats

Total funding raised
$70.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Private Equity
$70.0M in Jan 2022
Employees
101-250
reported band
Headquarters
London, United Kingdom

Latest funding round on record: Jan 2022.

iProov Funding Rounds

Date
Round
Amount
Private Equity
$70.0M

iProov Founders and Leadership Team

Name
Role
Contact
Andrew Bud
CEO

No contact details are on record for this team yet.

iProov Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round

iProov's latest round of $70.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like iProov in Biotechnology and London

Companies Similar to iProov

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

IMU is a discovery engine mapping the immune system to advance precision medicine.

Series A $38.4M

Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…

Undisclosed round $5.4M

Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…

Pre-Seed $740k

Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology.…

Undisclosed round

iProov Funding FAQs

What does iProov do?

iProov is a cyber-security business based in London, providing strong biometric identity authentication of online users. It focuses on enabling users to log into online services simply, yet, securely. iProov specializes in facial recognition software. iProov is led by a team combining senior experience in growing global, high performance mobile and cloud services, with world class academic research expertise. The business has won many innovation grants from InnovateUK and the UK Government's innovation agency. iProov was established in 2011.

How much funding has iProov raised?

iProov has raised $70.0M across 1 round on record. The most recent is a Private Equity of $70.0M announced in Jan 2022.

When did iProov last raise funding?

iProov's most recent funding round on record is a Private Equity of $70.0M, announced in Jan 2022.

Who is the CEO of iProov?

Andrew Bud is listed as CEO at iProov.

Where is iProov headquartered?

iProov is based in London, England, United Kingdom.

How many employees does iProov have?

iProov is in the 101-250 employee band.

How does iProov's funding compare to other Biotechnology startups?

iProov's latest round of $70.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's iProov Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for iProov is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.